[Antiphlogistic and analgesic effect of diclofenac sodium after maxillofacial interventions in a double-blind trial].
Diclofenac sodium (Voltaren) was tested over a period of six months in a double-blind experiment for its antiphlogistic and analgesic effect. A retained or impacted lower third molar was removed from each of the 138 patients studied. The postoperative course was evaluated in terms of the criteria of pain, trismus, swelling, and side effects; and the results were recorded. The swelling was objectified by photographic documentation and planimetric measurements. Our studies indicated that diclofenac sodium can also be recommended for the medicamentous prophylaxis of swelling and pain resulting from dental procedures.
D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002986:Clinical Trials as Topic; D004008:Diclofenac / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D008963:Molar; D010648:Phenylacetates / Q000627:therapeutic use*; D010919:Placebos; D011182:Postoperative Care; D013997:Time Factors; D014081:Tooth Extraction; D014095:Tooth, Impacted / Q000601:surgery
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010648:Phenylacetates; D010919:Placebos; D004008:Diclofenac
Uber die antiphlogistische und analgetische Wirkung von Diclofenac-Na nach kieferchirurgischen Eingriffen im Doppelblindversuch.